Discovery science

We speak with neurologist Katrin Andreasson about new links between inflammation, metabolism and new hopes for treating neurodegeneration

Join us as we look back on some of the key studies we covered here at Wu Tsai Neuro and the Knight Initiative in 2025 to give a (very partial) overview of the impact of our community’s research efforts this past year

Andreasson received the Inge Grundke-Iqbal Award for her work on restoring cognition in Alzheimer's. Karly Cody, a postdoctoral fellow in the lab of Knight Initiative researcher Elizabeth Mormino, was also honored.

Knight Initiative scientists report that biology, behavior, and circumstance all intertwine over a lifetime to influence how organs grow old

Amyotrophic lateral sclerosis and frontotemporal dementia are devastating neurodegenerative diseases. Knight Initiative postdoc Yi Zeng is working to understand the role a central protein plays in both diseases—and whether it might point toward new diagnostics and treatments

Research from Knight Initiative Director Tony Wyss-Coray's lab show that an Alzheimer's hallmark—myriad oily droplets in brain cells called microglia—may help connect several of the disorder’s better known but not well understood features.

Neurons are built to last, but with age, bad things can happen to them. Wu Tsai Neuro affiliate Katrin Andreasson's work shows a lot of it is triggered by what’s happening to immune cells outside of the brain.

A new study led by Wu Tsai Neuro Faculty Scholar Laura Gwilliams maps how we simultaneously process different words.

Organizers of the Wu Tsai Neurosciences Institute’s 12th annual symposium share exciting new discoveries from the frontiers of the “gut-brain axis.”

Amyloid plaques have long been the focus of Alzheimer’s therapies. But Wu Tsai Neuro's Emmanuel Mignot and others are focusing on the stringy tangles of a protein called tau, the unsung second hallmark of Alzheimer’s.